1McCullough PA, Philbin EF, Spenus JA, et al. Confirmation of a heart failure epiedmic: finding from the resource utilization among congestive heart failure (REACH)study[J]. J Am coll cardiol, 2000, 39(1):60-69.
4[1]Guijarro C.High-sensitivity C-reactive protein:potential adjunct for global risk assessmem in the primary prevention of cardiovascular disease[J].Circulation,2001,104(22):127.
5[2]Liuzzo G'Buffon A,Biasueci LM,et al.Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina[J].Circulation,1998,22:2370～2375.
6[3]Alpcrt JS,Thygesen K,Antman E,et al.Myocardial infarction redefined-a consensus document of the joint European Society of Cardiology Amercan College of Cardidogy Committee for the redefinition of myocardial infarction[J].JAM Coll Cardiol,2000,36(3):959～969.
7[4]Home BD,Muhlestein JB,Carlquist JF,et al.Statin therapy,lipid levels,C-reactive protein and the surdval of patients with angiographically severe coronary artery disease[J].J Am Coil Cardiol,2000,36(6):1774～1780.
8[3]Silver MA,Rosendorff C,Berkowitz R,et al.Current and emerging issues with B-type natriuretie peptide.Roundtable discussion[J].Congest Heart Fail,2005,11(4):212～214.
9[4]Cardarelli R,Lumicao TG Jr.B-Typo Natriuretic poptide:A review of its diagnostic,prognostic and therapeutic monitoring value in heart failure for'primary care physicians[J].J Am Board Faro Prat,2003,16(4):327～333.
10[5]Sudon T,Kangewa K,Minamina N,et al.A new natriuretic poptide in porcine brain[J].Nat ure,1988,332:78.
6Mueller C. The use ol" B-type natriur tic pcptide in coronary artery disease [ J ]. J Am Coil Cardio1,2007,50 ( 3 ) : 215-216.
7郭岂芳.欧洲心脏病泌会更新急性肺栓塞诊疗指南[J].临床荟荦,2010,25(17):IV.
8Kotaska K,Popelova J,Tiserova M,et al. NT-ProBNP and BNP val-ues in cardiac patients with different degree of leftventricular systolicdysfunction [J]. Biomed Pap Med Fac Univ Palacky Olomouc CzechRepub,2006,150(1):125-130.
9Palazzuoli A, Gallotta M, Quatrini I, et al. Natriuretic peptides(BNP and NT-proBNP): measurement and relevance in heart failure[J]. Vasc Health Risk Manag,2010,6(3):411-418.
10Egorova EN, Kuz'mina MI, Mazur VV, et al. Trends in systemic inflammatory factors and aminoterminal brain natriuretic propeptide in the treatment of chronic heart failure [ J ]. Kalinkin MN, Mazur ES ,Ter Arkh ,2011,83 ( 1 ) :56 - 9.
